We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
-1.26%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.29B
AUM Growth
+$61.5M
Cap. Flow
+$11.7M
Cap. Flow %
0.91%
Top 10 Hldgs %
37.9%
Holding
333
New
17
Increased
60
Reduced
147
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Financials 8.46%
3 Healthcare 7.38%
4 Consumer Discretionary 6.37%
5 Industrials 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDS icon
1
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.82B
$82.2M 6.36%
3,432,629
-2,020,062
-37% -$48.6M
DSTL icon
2
Distillate US Fundamental Stability & Value ETF
DSTL
$1.87B
$70.5M 5.45%
1,284,091
+285,917
+29% +$16.3M
AAPL icon
3
Apple
AAPL
$4.72T
$47.9M 3.7%
191,082
-1,073
-0.6% -$253K
MSFT icon
4
Microsoft
MSFT
$2.83T
$47.3M 3.65%
112,171
-2,019
-2% -$860K
SMTH icon
5
ALPS Smith Core Plus Bond ETF
SMTH
$2.93B
$47.1M 3.64%
+1,844,088
New +$47.7M
GLW icon
6
Corning
GLW
$134B
$44.3M 3.43%
932,446
-31,685
-3% -$1.5M
DCRE icon
7
DoubleLine Commercial Real Estate Debt ETF
DCRE
$452M
$43.2M 3.34%
+839,350
New +$43.2M
IVV icon
8
iShares Core S&P 500 ETF
IVV
$875B
$37.7M 2.92%
64,121
+30,298
+90% +$17.9M
LLY icon
9
Eli Lilly
LLY
$1.06T
$35.3M 2.73%
45,714
-2,037
-4% -$1.69M
IBDR icon
10
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.46B
$34.8M 2.69%
1,446,798
+33,623
+2% +$811K
TMO icon
11
Thermo Fisher Scientific
TMO
$213B
$30.6M 2.36%
58,740
-965
-2% -$531K
BSCQ icon
12
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.66B
$29.3M 2.27%
1,508,382
+322,142
+27% +$6.27M
JPM icon
13
JPMorgan Chase
JPM
$930B
$29.2M 2.26%
121,869
-2,435
-2% -$567K
RSP icon
14
Invesco S&P 500 Equal Weight ETF
RSP
$95.3B
$29.2M 2.25%
166,381
-8,833
-5% -$1.6M
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.06T
$28.4M 2.19%
62,638
-1,097
-2% -$507K
FSK icon
16
FS KKR Capital
FSK
$2.96B
$27.1M 2.1%
1,249,499
-36,617
-3% -$768K
CEF icon
17
Sprott Physical Gold and Silver Trust
CEF
$7.39B
$25.3M 1.95%
1,062,789
-507,063
-32% -$12.6M
TXN icon
18
Texas Instruments
TXN
$259B
$24.1M 1.87%
128,702
-1,431
-1% -$286K
QCOM icon
19
Qualcomm
QCOM
$180B
$23.2M 1.8%
151,235
-653
-0.4% -$107K
AVY icon
20
Avery Dennison
AVY
$11.9B
$22.3M 1.72%
119,215
-46
-0% -$9.39K
JCI icon
21
Johnson Controls International
JCI
$87.4B
$21.8M 1.69%
276,587
-67,692
-20% -$5.43M
GDX icon
22
VanEck Gold Miners ETF
GDX
$22.9B
$18.1M 1.4%
534,863
+521,042
+3,770% +$20M
AMZN icon
23
Amazon
AMZN
$2.51T
$18.1M 1.4%
82,592
-672
-0.8% -$137K
VO icon
24
Vanguard Mid-Cap ETF
VO
$106B
$17.7M 1.37%
268,344
+158,896
+145% +$10.8M
CRM icon
25
Salesforce
CRM
$129B
$17.6M 1.36%
52,764
+35
+0.1% +$11.2K

Similar funds

Shufro Rose & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Shufro Rose & Co held 333 positions worth $1.29B, up 5% from $1.23B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Shufro Rose & Co's Q4 2024 filing shows 17 new, 60 increased, 147 reduced and 33 closed positions. Its largest new stake was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $48.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Shufro Rose & Co's largest Q4 2024 buy was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M.
  • Shufro Rose & Co added most to VanEck Gold Miners ETF in Q4 2024, an estimated $20M increase.
  • Shufro Rose & Co's biggest Q4 2024 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $48.6M.
  • Shufro Rose & Co fully exited Moderna in Q4 2024, selling an estimated $17.4M.
  • Shufro Rose & Co's ten largest holdings make up 38% of its $1.29B portfolio in Q4 2024.
  • Shufro Rose & Co opened 17 new positions and closed 33 in Q4 2024.
  • Shufro Rose & Co's portfolio value rose 5% quarter-over-quarter to $1.29B.

Based on Shufro Rose & Co's 13F filing for Q4 2024, filed 25 Feb 2025.